Neurotensin Receptor 1 (NTSR1) Overexpression in Breast Carcinomas Is Common and Independent of ER/PR/Her2 Expression

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Neurotensin Receptor 1 (NTSR1) Overexpression in Breast Carcinomas Is Common and Independent of ER/PR/Her2 Expression"
written by Xianyong Gui, Shuhong Liu, Ziran Meng, Zu-Hua Gao,
published by Journal of Cancer Therapy, Vol.4 No.7A, 2013

has been cited by the following article(s):

[1]	Proof of Therapeutic Efficacy of a Novel 177Lu-Labeled Neurotensin Receptor 1-Antagonist in a Colon Carcinoma Xenograft Model
	2017

[2]	Proof of Therapeutic Efficacy of a 177Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model
	2017

[3]	Proof of Therapeutic Efficacy of a 177Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model.
	Journal of Nuclear Medicine, 2017

[4]	Synthesis of novel cancer selective theranostic nanodevicesSettore Scientifico Disciplinare CHIM/06
	Dissertation, 2017

Follow SCIRP